JPWO2021187602A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021187602A5
JPWO2021187602A5 JP2022508445A JP2022508445A JPWO2021187602A5 JP WO2021187602 A5 JPWO2021187602 A5 JP WO2021187602A5 JP 2022508445 A JP2022508445 A JP 2022508445A JP 2022508445 A JP2022508445 A JP 2022508445A JP WO2021187602 A5 JPWO2021187602 A5 JP WO2021187602A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022508445A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021187602A1 (https=
JP7785351B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/011232 external-priority patent/WO2021187602A1/ja
Publication of JPWO2021187602A1 publication Critical patent/JPWO2021187602A1/ja
Publication of JPWO2021187602A5 publication Critical patent/JPWO2021187602A5/ja
Application granted granted Critical
Publication of JP7785351B2 publication Critical patent/JP7785351B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022508445A 2020-03-19 2021-03-18 心筋細胞の精製方法 Active JP7785351B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2020050269 2020-03-19
JP2020050269 2020-03-19
JP2020145097 2020-08-28
JP2020145097 2020-08-28
PCT/JP2021/011232 WO2021187602A1 (ja) 2020-03-19 2021-03-18 心筋細胞の精製方法

Publications (3)

Publication Number Publication Date
JPWO2021187602A1 JPWO2021187602A1 (https=) 2021-09-23
JPWO2021187602A5 true JPWO2021187602A5 (https=) 2024-03-27
JP7785351B2 JP7785351B2 (ja) 2025-12-15

Family

ID=77768144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022508445A Active JP7785351B2 (ja) 2020-03-19 2021-03-18 心筋細胞の精製方法

Country Status (5)

Country Link
US (1) US20230212519A1 (https=)
EP (1) EP4123016A4 (https=)
JP (1) JP7785351B2 (https=)
CN (1) CN115427552A (https=)
WO (1) WO2021187602A1 (https=)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
BRPI0418732A (pt) 2004-04-10 2007-09-11 Henkel Kgaa dispositivo para enrolar cabelos
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US7661738B2 (en) 2006-11-28 2010-02-16 Veritainer Corporation Radiation detection unit for mounting a radiation sensor to a container crane
EP2626416A3 (en) 2007-04-07 2013-12-18 The Whitehead Institute for Biomedical Research Reprogramming of somatic cells
CN101802172A (zh) 2007-05-30 2010-08-11 通用医疗公司 由体细胞产生多能细胞的方法
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
AU2008297024B2 (en) * 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
AU2008333972A1 (en) * 2007-11-30 2009-06-11 New York Medical College Compositions comprising HDAC inhibitors and methods of their use in restoring stem cell function and preventing heart failure
JP2011521969A (ja) 2008-05-30 2011-07-28 スムマ ヘルス システムズ エルエルシー 眼疾患を治療するためのTGF−β受容体阻害剤又はアクチビン様キナーゼ(ALK)5阻害剤、A−83−01及びSB−431542の使用方法及び創傷治療条件
US20110305672A1 (en) * 2008-07-25 2011-12-15 University Of Georgia Research Foundation, Inc. COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME
US9550975B2 (en) 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
EP2691513A4 (en) * 2011-03-31 2014-09-03 Iheart Japan Corp NEW CARDIOMYOCYTE MARKER
WO2015058117A1 (en) * 2013-10-18 2015-04-23 Icahn School Of Medicine At Mount Sinai Directed cardiomyocyte differentiation and ventricular specification of stem cells
RU2728188C2 (ru) * 2014-07-16 2020-07-28 Хартсид Инк. Способ индуцирования гибели недифференцированных стволовых клеток без индукции гибели кардиомиоцитов и способ выделения кардиомиоцитов (варианты)
US10696948B2 (en) * 2014-09-16 2020-06-30 Osaka University Method for preparing pluripotent stem cell-derived cardiomyocyte population
JP2017104091A (ja) 2015-11-27 2017-06-15 タカラバイオ株式会社 間葉系細胞の製造方法
JP2017108705A (ja) * 2015-12-18 2017-06-22 国立大学法人京都大学 心筋細胞の製造方法
AU2021239654A1 (en) * 2020-03-19 2022-10-27 Orizuru Therapeutics, Inc. Cardiomyocyte purification method

Similar Documents

Publication Publication Date Title
JPWO2020261723A5 (https=)
JP2021008630A5 (https=)
JP2025146837A5 (https=)
JPWO2022064931A5 (https=)
JP2021531346A5 (https=)
JPWO2022044675A5 (https=)
JPWO2021085142A5 (https=)
JPWO2021171942A5 (https=)
JP2023150335A5 (https=)
JPWO2021201293A5 (https=)
JPWO2022138440A5 (https=)
JP2020152824A5 (https=)
JPWO2018075324A5 (https=)
JPWO2021132315A5 (https=)
JPWO2020023310A5 (https=)
JP2020028288A5 (https=)
JPWO2019225574A5 (https=)
JPWO2023105747A5 (https=)
JPWO2021172087A5 (https=)
JPWO2022259968A5 (https=)
JPWO2021065243A5 (https=)
JPWO2020246484A5 (https=)
JPWO2021192791A5 (https=)
JPWO2021132391A5 (https=)
JP2023098429A5 (https=)